These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Pharmacokinetics of cefoperazone concentration in human lung tissue]. Monden Y, Fujimoto Y, Nakahara K. Jpn J Antibiot; 1986 Jan; 39(1):57-62. PubMed ID: 3702062 [Abstract] [Full Text] [Related]
13. [A study of prostatic tissue levels of cefoperazone]. Yoshida H, Hoshino M, Haraguchi C, Ogawa Y, Kawai N, Sakurai H, Ishihara Y, Higaki Y, Imamura K. Hinyokika Kiyo; 1985 May; 31(5):871-4. PubMed ID: 2413746 [Abstract] [Full Text] [Related]
14. Pharmacokinetics of cefoperazone in patients undergoing chronic ambulatory peritoneal dialysis: clinical and pathophysiological implications. Hodler JE, Galeazzi RL, Frey B, Rudhardt M, Seiler AJ. Eur J Clin Pharmacol; 1984 May; 26(5):609-12. PubMed ID: 6468477 [Abstract] [Full Text] [Related]
18. [Study of cefoperazone in the field of obstetrics and gynecology. Susceptibility of clinical isolates to cefoperazone and cefoperazone concentrations in the exudate of the pelvic dead space]. Cho N, Kimura T, Suzuki H, Fukunaga K, Kunii K, Komoriyama Y. Jpn J Antibiot; 1984 Sep; 37(9):1607-19. PubMed ID: 6512980 [Abstract] [Full Text] [Related]
19. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology]. Ito K, Kondo H, Hayasaki M, Noda K. Jpn J Antibiot; 1984 Nov; 37(11):2193-202. PubMed ID: 6098712 [Abstract] [Full Text] [Related]
20. [Pharmacokinetics of cefoperazone in liver diseases]. Kakiuchi S, Tagawa S, Tameda Y, Kosaka Y. Jpn J Antibiot; 1985 Aug; 38(8):2026-32. PubMed ID: 4078997 [Abstract] [Full Text] [Related] Page: [Next] [New Search]